qXR
Screen chest X-rays for signs that warrant a closer look.
Qure AI Funding History
Qure AI develops medical imaging software for chest X-ray screening, head CT triage and musculoskeletal radiology. Public health programs use its tools to screen for conditions including tuberculosis.
Company Overview
Qure AI
Mumbai, India
Official WebsiteQure AI Funding Timeline
Series B
US$40 million
Qure planned to expand its medical imaging AI into more markets and invest in product development.
Led by Novo Holdings, HealthQuad.
Source · crunchbase.com ↗Series A
US$16 million
Qure.ai said the financing would support international expansion and further development of its radiology tools.
Led by Peak XV Partners.
Source · prnewswire.com ↗Series D
US$65 million
Qure.ai said the funding would support expansion in the United States and further development of its healthcare AI tools.
Led by Lightspeed Venture Partners. Participation included Novo Holdings.
Source · globenewswire.com ↗
Qure AI Founding Team
Prashant Warier and Pooja Rao brought deep learning and clinical research expertise together when they started Qure.ai. The team applied that combination to interpreting medical images, including chest X-rays and head CT scans.
Qure AI Products
Qure AI Company Development
Emergency Triage Expands the Imaging Portfolio
Qure.ai's chest X-ray work spans screening programs such as tuberculosis detection. Its head CT tools take the software into a different setting, where a flagged scan can help clinicians prioritize a case in an emergency imaging queue.
Qure AI Competitive Landscape
Screening Reach and Hospital Workflow
Qure.ai and Viz.ai overlap in scan triage, but the public-health side of Qure.ai's work brings a different deployment challenge: running chest X-ray screening beyond the hospital specialist network. Viz.ai emphasizes connecting a suspected finding with the clinicians who need to coordinate care.
